The invention relates to combinations of 4 [(S) 2 Azetidin 1 yl 1 (4 chloro 3 trifluoromethyl phenyl) ethylamino] quinazoline 8 carboxylic acid amide and/or its physiologically acceptable salts and solvates and an inhibitor of Her2 and the use of such combinations for the treatment of cancer.